Randomised trial examining clinical and cost effectiveness of three antithrombotic regimens following endovascular lower limb revascularisation for chronic limb threatening ischaemia: CLARITY (CLopidogrel, Aspirin and RIvaroxaban after revascularIsation with angioplasTY)